The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas
- PMID: 8782823
- DOI: 10.1038/ng0996-78
The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas
Abstract
Basal cell carcinoma (BCC) is the most common cancer in humans. The majority of sporadic BCCs have allele loss on chromosome 9q22 implying that inactivation of a tumour suppressor in this region is an important step in BCC formation. The gene for nevoid basal cell carcinoma syndrome (NBCCS), an autosomal dominant disorder characterized by multiple BCCs, maps to the same region and is presumed to be the tumour suppressor inactivated at this site. NBCCS has been identified recently and encodes a protein with strong homology to the Drosophila segment polarity gene, patched. Analysis of Drosophila mutants indicates that patched interacts with the hedgehog signalling pathway, repressing the expression of various hedgehog target genes including wingless, decapentaplegic and patched itself. Using single strand conformational polymorphism (SSCP) to screen human patched in 37 sporadic BCCs, we detected mutations in one-third of the tumours. Direct sequencing of two BCCs without SSCP variants revealed mutations in those tumours as well suggesting that inactivation of patched is probably a necessary step in BCC development. Northern blots and RNA in situ hybridization showed that patched is expressed at high levels in tumour cells but not normal skin suggesting that mutational inactivation of the gene leads to overexpression of mutant transcript owing to failure of a negative feedback mechanism.
Comment in
-
Is human patched the gatekeeper of common skin cancers?Nat Genet. 1996 Sep;14(1):7-8. doi: 10.1038/ng0996-7. Nat Genet. 1996. PMID: 8782809 Review. No abstract available.
Similar articles
-
Developmental genes and cancer: role of patched in basal cell carcinoma of the skin.J Natl Cancer Inst. 1997 Aug 6;89(15):1103-9. doi: 10.1093/jnci/89.15.1103. J Natl Cancer Inst. 1997. PMID: 9262247 Review.
-
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.Br J Dermatol. 2005 Jan;152(1):43-51. doi: 10.1111/j.1365-2133.2005.06353.x. Br J Dermatol. 2005. PMID: 15656799
-
Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation.Cancer Res. 1996 Oct 15;56(20):4562-5. Cancer Res. 1996. PMID: 8840960
-
The spectrum of patched mutations in a collection of Australian basal cell carcinomas.Hum Mutat. 2000;16(1):43-8. doi: 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.0.CO;2-7. Hum Mutat. 2000. PMID: 10874304
-
The hedgehog pathway and basal cell carcinomas.Hum Mol Genet. 2001 Apr;10(7):757-62. doi: 10.1093/hmg/10.7.757. Hum Mol Genet. 2001. PMID: 11257109 Review.
Cited by
-
Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment.Molecules. 2024 Feb 4;29(3):728. doi: 10.3390/molecules29030728. Molecules. 2024. PMID: 38338469 Free PMC article. Review.
-
Hedgehog-Related Mutation Causes Bone Malformations with or without Hereditary Gene Mutations.Int J Mol Sci. 2023 Aug 17;24(16):12903. doi: 10.3390/ijms241612903. Int J Mol Sci. 2023. PMID: 37629084 Free PMC article. Review.
-
Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies.Signal Transduct Target Ther. 2023 Aug 18;8(1):315. doi: 10.1038/s41392-023-01559-5. Signal Transduct Target Ther. 2023. PMID: 37596267 Free PMC article. Review.
-
The Immune Microenvironment in Basal Cell Carcinoma.Ann Dermatol. 2023 Aug;35(4):243-255. doi: 10.5021/ad.22.042. Ann Dermatol. 2023. PMID: 37550225 Free PMC article. Review.
-
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications.Int J Mol Sci. 2023 Feb 23;24(5):4430. doi: 10.3390/ijms24054430. Int J Mol Sci. 2023. PMID: 36901857 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical